[CLDX] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
26-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -13.19%
YoY- -82.80%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 4,131 1,613 333 3,786 887 1,764 3,456 3.01%
PBT -43,306 -26,487 -20,148 -22,839 -10,447 -9,402 -22,923 11.17%
Tax 13,384 -2,796 -874 -939 -4,448 -8,746 -19,082 -
NP -43,306 -23,691 -20,148 -21,900 -10,447 -9,402 -3,841 49.71%
Tax Rate - - - - - - - -
Total Cost 47,437 25,304 20,481 25,686 11,334 11,166 7,297 36.59%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -1,048.32 -1,468.75 -6,050.45 -578.45 -1,177.79 -532.99 -111.14 45.33%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.83 -0.50 -0.43 -0.55 -0.64 -0.81 -0.42 12.01%
EPS Diluted -0.83 -0.50 -0.43 -0.55 -0.64 -0.81 -0.41 12.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.